Biotech Exec Gets 7 Years in Prison for False Claims About Rapid Covid-19 Test – The New York Times

The former chief executive of a biotechnology company who, during the early days of the pandemic, falsely claimed that he had invented a blood test that could detect Covid-19 in 15 seconds was sentenced on Friday to seven years in prison for securities fraud, federal prosecutors said.

From February 2020 to December 2020, the former executive, Keith Berman, 70, of Westlake Village, Calif., engaged in a scheme to defraud people into investing in his company, Decision Diagnostics Corporation, by claiming the test could detect Covid using a finger prick sample of blood, prosecutors said.

In March and April 2020, Mr. Berman issued 12 false and misleading news releases describing the rapid Covid test, which his company called GenViro, prosecutors wrote. Decision Diagnostics stock price jumped by more than 1,500 percent during the period, prosecutors said.

In reality, prosecutors said, Mr. Berman had privately confided in a friend the test could not actually detect Covid-19.

Prosecutors accused Mr. Berman, the sole director of the publicly traded medical device company, of capitalizing on peoples fears about the pandemic in an effort to resuscitate the companys fortunes.

Mr. Bermans scheme resulted in about $28 million in investor losses, prosecutors said. Mr. Berman was indicted in December 2020, and he pleaded guilty in December 2023 to securities fraud, wire fraud and obstruction of an official proceeding.

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit andlog intoyour Times account, orsubscribefor all of The Times.

Thank you for your patience while we verify access.

Already a subscriber?Log in.

Want all of The Times?Subscribe.

Read the original post:

Biotech Exec Gets 7 Years in Prison for False Claims About Rapid Covid-19 Test - The New York Times